跳转至内容
Merck
CN

SML4098

RO4929097

≥98% (HPLC)

别名:

2,2-Dimethyl-N-((S)-6-oxo-6,7-dihydro-5H-dibenzo[b, d]azepin-7-yl)-N′-(2,2,3,3,3-pentafluoro-propyl)-malonamide, N1-[(7S)-6,7-Dihydro-6-oxo-5H-dibenz[b,d]azepin-7-yl]-2,2-dimethyl-N3-(2,2,3,3,3-pentafluoropropyl)propanediamide, RO 4929097, RO-4929097

登录 查看组织和合同定价。

选择规格

变更视图

关于此项目

经验公式(希尔记法):
C22H20F5N3O3
化学文摘社编号:
分子量:
469.40
MDL number:
NACRES:
NA.28
Assay:
≥98% (HPLC)
Form:
powder
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


Quality Segment

assay

≥98% (HPLC)

form

powder

color

white to beige

solubility

DMSO: 2 mg/mL, clear

storage temp.

-10 to -25°C

SMILES string

O=C1[C@H](C2=C(C3=C(N1)C=CC=C3)C=CC=C2)NC(C(C)(C(NCC(F)(C(F)(F)F)F)=O)C)=O

Biochem/physiol Actions

Orally active, potent and selective gamma-secretase inhibitor with anti-cancer efficacy in vitro and in vivo.

RO4929097 is an orally active, potent and selective gamma-secretase (γ-secretase) inhibitor (IC50 = 4 nM) that blocks Aβ1-40 production (IC50 = 14 nM in APP-overexpressing HEK293) and suppresses Notch signaling (IC50 = 5 nM by reporter assays) with >100-fold selectivity over 75 other enzymes, receptors and ion channels. RO4929097 reduces the size of MDA-MB-468 soft agar colonies in cultures (100-250 nM) and effectively suppresses A549 NSCLC xenografts-derived tumor growth in mice in vivo (3-60 mg/kg bid or qd p.o.).


pictograms

Exclamation mark

signalword

Warning

hcodes

Hazard Classifications

Acute Tox. 4 Oral

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库